|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| OPERATING EXPENSES | |||||
| General and administrative | |||||
| Research and development | |||||
| Impairment of acquired in-process research and development intangible assets | |||||
| Total operating expenses | |||||
| LOSS FROM OPERATIONS | |||||
| OTHER INCOME, NET | |||||
| NET LOSS | |||||
| Gain (loss) on foreign currency translation | |||||
| Total comprehensive loss | |||||
| Net loss per common share – basic (in Dollars per share) | |||||
| Net loss per common share – diluted (in Dollars per share) | |||||
| Weighted average number of common shares outstanding – basic (in Shares) | |||||
| Weighted average number of common shares outstanding – diluted (in Shares) | |||||
Loading...